Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Biotechnology — Depreciation: $44M in Q3 2026, up 15.8% from a year earlier.
Latest, Q3 2026
44
Period ended Sep 30, 2026
Change on a year earlier
+15.8%
38 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
11
Documents cited below
Where the Q3 2026 figure comes from
Source: Danaher IR — nongaap_2026Q3 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Danaher Biotechnology — Depreciation ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/seg-depr-ir-biotech
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.